Max Jones
5 posts
Max Jones is the producer for The Chris Hedges Report. After graduating summa cum laude from the University of Southern California in 2023, his work has been published in Unlimited Hangout, ScheerPost and republished at Popular Resistance. He has also interviewed a wide range of figures including John Kiriakou and Ray McGovern. You can support him directly at antijones.substack.com and follow him on X, @maxyyjones.
Cold Harbor: Eugenics, Epstein and Big Tech
In the recent cache of Jeffrey Epstein emails unveiled by Bloomberg, Epstein’s connections to the elites of academia illuminate his interest in transhumanism, or neo-eugenics — a philosophy that has become commonplace among Big Tech oligarchs and ruling class elites. Shaping the development of pharmaceutical products, inspiring emergency-based deregulation and dovetailing with the expansion of the biomedical surveillance state, the material implications of this belief system are consequential and widespread.
November 6, 2025
Meet Trump’s CDC Director: Susan Monarez
A closer look at the CDC director’s history and connections reveal that her government career is closely linked to the intersections of re-branded eugenics, the militarization of healthcare and the expansion of the bio-surveillance state.
August 18, 2025
Thiel-Linked HHS Nominee Threatens MAHA Ambitions with Biotech Stance
Biotech investor and Peter Thiel associate Jim O'Neill is poised to usher in a deregulatory paradigm that would allow a proliferation of dubious products on the US market under the guise of "innovation" and "efficiency."
January 28, 2025
The CDC, Palantir and the AI-Healthcare Revolution
The CDC’s Center for Forecasting and Outbreak Analytics (CFA) has partnered with the CIA-linked Palantir to cement the public-private model of invasive surveillance in “public health,” all while pushing the U.S. national security state and Silicon Valley even closer together.
January 13, 2025
The WHO: Building a Permanent Pandemic Market
In the face of a potentially industry-ending slew of patent cliffs, Big Pharma has begun acquiring biotechnology companies to stave off collapse. To get these drugs to market, the industry is pursuing the only solution left for their dying model: a full takeover of the WHO to capture the global regulatory system.
July 3, 2024